Most recent update: Thursday, February 20, 2020 - 14:15

Bariatric News - Cookies & privacy policy

You are here Top 10 most read articles in June 2016

Just in case you missed any news in June 2016, these were the 10 most read articles on including the latest research, product & industry news, policy news and more...

Sensory neurons show how surgery achieves weight loss

The vagus nerve has long been recognised as the internal sensory system, regulating breathing and heart rate among, as well as sensing and signalling that feeling of fullness to the brain. That same nerve also detects nutrients and controls digestion. Yet how it receives the information it uses to perform these tasks has been less well-known...(more)

First successful bariatric application for LapDome device

Narvitas Medical Devices International Limited, a UK-based global medical device company, has announced the successful use of its LapDome in a patient that would be medically categorised as morbidly obese. LapDome, which the company claims is the first commercially available laparoscopic surgery access device, is designed to provide safer and more rapid access to the abdominal cavity at the outset of laparoscopic surgery. The procedure was performed on a patient weighing 308lbs with a BMI49 by Dr Andreas Thurkow, in the Netherlands...(more)

Stretta GERD treatment can yield substantial cost savings

Researchers from Baker Tilly LLP, Fairleigh Dickinson University and Stanford University, has suggested the potential for substantial payer cost savings associated with radiofrequency energy (RFE, Stretta Therapy, Mederi Therapeutics) treatment of gastroesophageal reflux disease (GERD) patients, compared to treatment with medical management or fundoplication. The study, ‘Budget Impact Analysis to Estimate the Cost Dynamics of Treating Refractory Gastroesophageal Reflux Disease With Radiofrequency Energy: a Payer Perspective’, is published in Managed Care...(more)

Whole-person perspective is needed to assess obesity

Researchers from the Cleveland Clinic's Bariatric and Metabolic Institute have recommended physicians use obesity staging models to recognise and manage weight-related health issues, which may not be captured by traditional diagnosis criteria. The authors urge physicians to take a broader view of what constitutes obesity, which is traditionally defined as a BMI>30. The review article, ‘Comprehensive Evaluation for Obesity: Beyond Body Mass Index’, was published in the Journal of the American Osteopathic Association...(more)

New pre- and post-bariatric surgery diet resources launched

NDR-UK has launched two innovative new resources, developed by specialist dietetic colleagues at NHS Ayrshire and Arran, Scotland. The comprehensive, 80 page book is designed to support patients before and after gastric sleeve and gastric bypass surgery (not gastric band surgery - for information on this, please see resource 9014)...(more)

Medtronic makes investment in Dutch Obesity Clinic

The Nederlandse Obesitas Kliniek (Dutch Obesity Clinic, NOK) and Medtronic have announced that an agreement to enter into a strategic alliance, via a majority ownership position in NOK, with the goal of enhancing NOK's ability to offer integrated, value-based healthcare solutions for the treatment of morbid obesity to more patients, in more locations around the world...(more)

Little evidence of benefits for T2DM weight loss programmes

Johns Hopkins scientists who indirectly investigated the blood sugar effects of ten (out of 32 selected) commercial weight loss programmes have noted a few show promise of benefit for diabetic patients, but far more rigorous research is needed before doctors can wholeheartedly recommend them...(more)

EndoStim announces GERD data following EndoStim therapy

EndoStim has announced new data were presented on its new neurostimulation therapy for gastro-oesophageal reflux disease (GERD) at the 2016 Digestive Disease Week (DDW) meeting in San Diego, California. The four presentations included analyses of: one year results of an international multi-center study of EndoStim therapy for refractory GERD; and interim results from EndoStim's international patient registry...(more)

Surgery more effective than MT for T2DM in teens

An analysis of the results of a study of bariatric surgery and a separate trial of medical therapy in treating type 2 diabetes in teenagers with severe obesity shows that after two years of treatment, BMI and HbA1c, a measure of blood sugar control, are both significantly better with surgery. The results were presented at the annual meeting of the American Diabetes Association in New Orleans...(more)

FDA approves AspireAssist system as alternative to surgery

The FDA has approved the AspireAssist System, an endoscopic alternative to weight loss surgery for people with moderate to severe obesity. According to the company behind AspireAssist, Aspire Bariatrics, the system provides the patient with a method for achieving effective ‘portion control’ of food intake at the level of the stomach, which lowers the threshold for successful weight loss and facilitates lifestyle behaviour change for long-term weight management...(more)